Literature DB >> 2798242

Vancomycin prophylaxis and elective total joint arthroplasty.

M A Ritter1, C D Barzilauskas, P M Faris, E M Keating.   

Abstract

A series of 201 consecutive patients treated with unilateral or bilateral total joint arthroplasty were given a single-dose prophylactic antibiotic regimen consisting of 1 g vancomycin infused over 1 hour on the morning of surgery and 80 g gentamicin given upon arrival in the operating room. Bactericidal blood levels were maintained during and for 24 hours after surgery. Elevated serum creatinine levels developed postsurgically in 8 patients but returned to normal. No serious hypersensitivity reactions occurred; minor reactions responded to antihistamine therapy. No postoperative infections were reported. Cost of administration compared favorably with 24- and 48-hour regimens employing cephalosporins. The investigators concluded that a combined single dose vancomycin/gentamicin regimen is a safe, effective, and cost efficient method of orthopedic implant prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2798242     DOI: 10.3928/0147-7447-19891001-09

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  8 in total

1.  Does dual antibiotic prophylaxis better prevent surgical site infections in total joint arthroplasty?

Authors:  Amy Sewick; Amun Makani; Chia Wu; Judith O'Donnell; Keith D Baldwin; Gwo-Chin Lee
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

Review 2.  Cost-effective prophylaxis of surgical infections.

Authors:  S R Norrby
Journal:  Pharmacoeconomics       Date:  1996-08       Impact factor: 4.981

3.  Staphylococcal persistence due to biofilm formation in synovial fluid containing prophylactic cefazolin.

Authors:  Sana S Dastgheyb; Sommer Hammoud; Constantinos Ketonis; Andrew Yongkun Liu; Keith Fitzgerald; Javad Parvizi; James Purtill; Michael Ciccotti; Irving M Shapiro; Michael Otto; Noreen J Hickok
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

4.  Targeted use of vancomycin as perioperative prophylaxis reduces periprosthetic joint infection in revision TKA.

Authors:  Catherine Liu; Anthony Kakis; Amy Nichols; Michael D Ries; Thomas P Vail; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

Review 5.  Prevention and management of prosthetic joint infection in older adults.

Authors:  Emily K Shuman; Preeti N Malani
Journal:  Drugs Aging       Date:  2011-01-01       Impact factor: 3.923

Review 6.  Methicillin-resistant staphylococci in clean surgery. Is there a role for prophylaxis?

Authors:  E Mini; S Nobili; P Periti
Journal:  Drugs       Date:  1997       Impact factor: 9.546

7.  The standard one gram dose of vancomycin is not adequate prophylaxis for MRSA.

Authors:  Anthony Catanzano; Michael Phillips; Yanina Dubrovskaya; Lorraine Hutzler; Joseph Bosco
Journal:  Iowa Orthop J       Date:  2014

8.  The Mark Coventry Award: Higher tissue concentrations of vancomycin with low-dose intraosseous regional versus systemic prophylaxis in TKA: a randomized trial.

Authors:  Simon W Young; Mei Zhang; Joshua T Freeman; John Mutu-Grigg; Paul Pavlou; Grant A Moore
Journal:  Clin Orthop Relat Res       Date:  2014-01       Impact factor: 4.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.